Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the Common Stock, $0.0001 par value, of Nektar Therapeutics. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such joint filing and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.

EXECUTED as of this 17th day of April, 2026.

	TWO SEAS CAPITAL LP

	By:		Two Seas Capital GP LLC, its general partner

	By:		/s/ Sina Toussi
	Name:		Sina Toussi
	Title:		Managing Member

	TWO SEAS CAPITAL GP LLC

	By:		/s/ Sina Toussi
	Name:		Sina Toussi
	Title:		Managing Member
	SINA TOUSSI

	By:		/s/ Sina Toussi

NEKTAR THERAPEUTICS SCHEDULE 13G